Donor lymphocyte transfusion for relapse after allogeneic bone marrow transplantation

Keyphrases

• Donor Lymphocytes 100%
• Leukemia 100%
• Graft-versus-host Disease (GvHD) 100%
• Chronic Myeloid Leukemia 100%
• Donor Lymphocyte Infusion 100%
• Allogeneic Bone Marrow Transplantation 100%
• Remission 66%
• Interferon-α (IFN-α) 66%
• Marrow 66%
• Transfusion 66%
• Mortality Rate 33%
• Response Rate 33%
• Treatment Choice 33%
• Adoptive Immunotherapy 33%
• Polymerase Chain Reaction 33%
• Transplantation Tolerance 33%
• Multiple Myeloma 33%
• Acute Lymphoblastic Leukemia 33%
• Poor Prognosis 33%
• BCR-ABL 33%
• Philadelphia Chromosome 33%
• Complete Remission 33%
• Acute Myeloid Leukemia 33%
• Myelodysplastic Syndrome 33%
• Leukemia Patients 33%
• Cytopenia 33%
• Aplasia 33%
• Hematologic 33%
• Chimerism 33%
• Degree of Severity 33%
• Leukemia Therapy 33%
• Cytogenetic Remission 33%
• Molecular Remission 33%
• Haematological Remission 33%

Medicine and Dentistry

• Chronic Myelogenous Leukemia 100%
• Allogenic Bone Marrow Transplantation 100%
• Lymphocyte Transfusion 100%
• Leukemia 100%
• Graft Versus Host Reaction 100%
• Lymphocyte 100%
• Interferon 66%
• Mortality Rate 33%
• Multiple Myeloma 33%
• Adoptive Immunotherapy 33%
• Acute Lymphoblastic Leukemia 33%
• Myelodysplastic Syndrome 33%
• Acute Myeloid Leukemia 33%
• Antileukemic Agent 33%
• Aplasia 33%
• Cytopenia 33%
• Transplantation Tolerance 33%
• Philadelphia Chromosome Positive Cell 33%
• Polymerase Chain Reaction 33%